Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears PhotoMedex' laser for leukoderma:

This article was originally published in Clinica

Executive Summary

PhotoMedex has received US FDA clearance to expand the use of its XTRAC laser system to the treatment of leukoderma, the loss of skin pigmentation often a result of injury to the skin caused by trauma, surgery, laser therapy and burns. The device stimulates melanocyte migration and proliferation by the release of cytokines and inflammatory mediators in the skin, which lead to re-pigmentation, says the Radnor, Pennsylvania firm. The laser is already cleared for treating psoriasis, vitiligo and eczema.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel